Willis Towers Watson plc 8.3
Source: RNS
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
|
Name of person dealing (Note 1) |
J.P. Morgan Securities LLC |
|
Company dealt in |
Willis Towers Watson plc |
|
Class of relevant security to which the dealings being disclosed relate (Note 2) |
US$0.000304635 ordinary shares |
|
Date of dealing |
22 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
|
|
Long |
Short |
||||
|
|
Number |
|
(%) |
Number |
|
(%) |
|
(1) Relevant securities |
1,796,285 1.39 |
1,760,041 1.36 |
||||
|
(2) Derivatives (other than options) |
1,609,191 1.25 |
1,641,400 1.27 |
||||
|
(3) Options and agreements to purchase/sell
|
2,000 0.00 |
26,000 0.02 |
||||
|
Total |
3,407,476 2.64 |
3,427,441 2.65 |
||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
|
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
|
Purchase (New Borrow)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales |
100
35 1 3 1 3 4 207 4 4 1 4 2 8,100 2 700 216 100 7,084 50,272 2 1 2 2
35 5 127 6,734 86 1 733 497 1,013 965 84 24 1,038 10 86 10 130 4 833 2,173 670 196 86 1,078 3,647 613 736 174 32 4 81 88 202 6 79 86 87 56 245 274 5 109 385 354 26 1 10 12 87 265 109 831 54 8,100 5 25 50,272 428 1 26 136 33 88 40 1 633 1,460 11 182 63 3,504 |
N/A
224.6200 USD 226.5800 USD 226.3967 USD 226.1800 USD 226.5167 USD 226.4625 USD 226.3400 USD 226.2600 USD 226.1525 USD 226.4400 USD 225.9300 USD 226.6500 USD 226.3282 USD 226.3600 USD 226.3214 USD 226.5561 USD 226.4643 USD 226.3143 USD 226.2519 USD 226.2850 USD 226.7300 USD 226.4850 USD 226.1750 USD
224.6200 USD 226.2200 USD 226.5700 USD 226.3400 USD 226.4400 USD 226.3275 USD 226.2817 USD 225.9495 USD 226.2705 USD 226.0315 USD 225.9400 USD 226.6400 USD 226.2744 USD 226.2650 USD 225.9300 USD 226.0750 USD 226.0900 USD 226.1300 USD 226.3321 USD 226.2822 USD 226.0275 USD 226.2603 USD 226.6800 USD 226.1563 USD 226.1458 USD 226.4184 USD 226.1347 USD 226.0700 USD 226.2100 USD 226.1000 USD 226.0600 USD 226.0800 USD 226.5085 USD 226.1500 USD 226.8200 USD 225.9100 USD 226.0000 USD 226.1400 USD 226.1100 USD 226.7208 USD 226.4000 USD 226.6500 USD 226.6851 USD 226.7548 USD 226.6700 USD 226.7750 USD 226.6450 USD 226.6600 USD 226.0500 USD 226.2167 USD 226.4412 USD 226.0247 USD 226.5000 USD 226.3282 USD 225.8200 USD 226.3600 USD 226.2519 USD 226.1581 USD 226.9850 USD 226.3100 USD 226.5920 USD 226.1600 USD 226.2300 USD 226.6150 USD 226.5300 USD 226.6706 USD 226.6277 USD 226.6250 USD 226.2766 USD 225.8500 USD 226.1518 USD |
(b) Derivatives transactions (other than options transactions)
|
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (USD) (Note 5) |
|
Equity Swap |
Decrease Short
Increase Long
Increase Short
Decrease Long |
25,136
6,400
8,100
2 |
226.2469 USD
226.3400 USD
226.3282 USD
226.3604 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price (USD) |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) (USD) |
|
|
|
|
|
|
|
|
(ii) Exercising
|
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
|
Date of disclosure |
23 July 2021 |
|
Contact name |
Alwyn Basch |
|
Telephone number |
0207 742 7407 |
|
If a connected EFM, name of offeree/offeror with which connected |
N/A |
|
If a connected EFM, state nature of connection (Note 10) |
N/A |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
|
Product name, e.g. call option |
Written, or purchased |
Number of relevant securities to which the option or derivative relates |
Exercise price (Note 2) (USD) |
Type, e.g. American, European etc. |
Expiry date |
|
Call Option Call Option Put Option
|
Purchased Written Written
|
2,000 2,000 24,000
|
230.00 230.00 220.00
|
American American American
|
17/09/2021 20/08/2021 20/08/2021
|
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
